Johnson & Johnson
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
(0.0% 1d) (-4.6% 1m) (-8.7% 1y) (0.0% 2d) (-0.8% 3d) (0.4% 7d) (NaN% volume)
Earnings Calendar: 2024-01-23
Market Cap: $ 357,925,077,011
http://www.jnj.com
Sec Filling | Patents | 132200 employees
(US) Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
vaccine cardiovascular eye infectious disease diabetes diabetic hypertension urea pulmonary hypertension women health immunology metabolic women
add to watch list Paper trade email alert is off
Press-releases
Why Biopharma Companies Avoid Hiring People Who Need Visas
Published: 2024-04-25 (Just crawled : 05:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
companies avoid biopharma
Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034 | DelveInsight
Published: 2024-04-24 (Crawled : 22:00) - prnewswire.com
KOD | News | $3.37 1.2% 1.19% 340K
|
Health Technology
| Email alert
Add to watchlist
OPT | News | $3.46 2.98% 2.89% 8.2K
|
Health Technology
| Email alert
Add to watchlist
OTLK | News P | $8.2 0.0% 240K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
disease market
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Published: 2024-04-24 (Crawled : 21:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
NBTX | $5.71 1.04% 1.4K
|
Manufacturing
| Email alert
Add to watchlist
business year update financial results
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
CDTX | News | $11.94 16.49% 14.15% 170K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
cd388 million global commercial therapeutics development
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Published: 2024-04-24 (Crawled : 08:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K
|
n/a
|
| O: 1.12%
H: 1.48%
C: -0.07%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
avt05 simponi biosimilar for topline results study
Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors
Published: 2024-04-24 (Crawled : 07:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
precision company million series therapeutics
Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 05:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
RLYB | News | $1.59 -8.62% -9.43% 280K
|
|
| O: -3.05%
H: 0.0%
C: -9.71%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
VXRT | News | $0.7051 -5.41% -5.72% 1.5M
|
Health Technology
|
| O: -1.94%
H: 0.0%
C: -6.58%
TXMD | News | $1.88 -0.27% 15K
|
Health Technology
|
| O: 0.53%
H: 2.12%
C: 1.59%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
PTCT | News S | $25.19 -0.87% -0.87% 560K
|
Health Technology
|
| O: -0.71%
H: 0.81%
C: -2.25%
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: -1.08%
H: 3.65%
C: 0.73%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 0.0%
H: 0.28%
C: 0.06%
GLPG | News | $28.78 -2.28% -2.33% 140K
|
Health Technology
|
| O: 0.48%
H: 0.17%
C: -1.88%
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 0.57%
H: 1.14%
C: 0.0%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M
|
Technology Services
|
| O: 0.29%
H: 1.31%
C: 1.04%
GOOG | News 4 | $161.05 0.71% 0.7% 19M
|
Technology Services
|
| O: 0.32%
H: 1.45%
C: 1.26%
OCX | News | $2.3 -6.31% -6.74% 41K
|
Health Technology
|
| O: 2.03%
H: 0.0%
C: -1.99%
biopharma
Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development
Published: 2024-04-24 (Crawled : 08:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
drug for therapeutics development
Biopharma Layoff Tracker 2024: Tessera, BMS, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
RLYB | News | $1.59 -8.62% -9.43% 280K
|
|
| O: -3.05%
H: 0.0%
C: -9.71%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
VXRT | News | $0.7051 -5.41% -5.72% 1.5M
|
Health Technology
|
| O: -1.94%
H: 0.0%
C: -6.58%
TXMD | News | $1.88 -0.27% 15K
|
Health Technology
|
| O: 0.53%
H: 2.12%
C: 1.59%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
PTCT | News S | $25.19 -0.87% -0.87% 560K
|
Health Technology
|
| O: -0.71%
H: 0.81%
C: -2.25%
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: -1.08%
H: 3.65%
C: 0.73%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 0.0%
H: 0.28%
C: 0.06%
GLPG | News | $28.78 -2.28% -2.33% 140K
|
Health Technology
|
| O: 0.48%
H: 0.17%
C: -1.88%
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 0.57%
H: 1.14%
C: 0.0%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M
|
Technology Services
|
| O: 0.29%
H: 1.31%
C: 1.04%
GOOG | News 4 | $161.05 0.71% 0.7% 19M
|
Technology Services
|
| O: 0.32%
H: 1.45%
C: 1.26%
OCX | News | $2.3 -6.31% -6.74% 41K
|
Health Technology
|
| O: 2.03%
H: 0.0%
C: -1.99%
biopharma
BigHat Biosciences Enters Into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
antibody collaboration design
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 10000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10